These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
596 related items for PubMed ID: 16604529
1. Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990. Wakelee HA, Bernardo P, Johnson DH, Schiller JH. Cancer; 2006 May 15; 106(10):2208-17. PubMed ID: 16604529 [Abstract] [Full Text] [Related]
2. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases]. Cai Y, Wang WL, Xu B, Zhu GY, Zhang SW. Ai Zheng; 2006 Nov 15; 25(11):1419-22. PubMed ID: 17094913 [Abstract] [Full Text] [Related]
3. A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials. Mandrekar SJ, Schild SE, Hillman SL, Allen KL, Marks RS, Mailliard JA, Krook JE, Maksymiuk AW, Chansky K, Kelly K, Adjei AA, Jett JR. Cancer; 2006 Aug 15; 107(4):781-92. PubMed ID: 16847887 [Abstract] [Full Text] [Related]
5. Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials. Hicks LK, Cheung MC, Ding K, Hasan B, Seymour L, Le Maître A, Leighl NB, Shepherd FA. Cancer; 2009 Dec 01; 115(23):5516-25. PubMed ID: 19711465 [Abstract] [Full Text] [Related]
6. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer? Radosavljevic D, Golubicic I, Gavrilovic D, Kezic I, Jelic S. J BUON; 2009 Dec 01; 14(2):203-9. PubMed ID: 19650167 [Abstract] [Full Text] [Related]
10. Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer. Butts C, Murray N, Maksymiuk A, Goss G, Marshall E, Soulières D, Cormier Y, Ellis P, Price A, Sawhney R, Davis M, Mansi J, Smith C, Vergidis D, Ellis P, MacNeil M, Palmer M. J Clin Oncol; 2005 Sep 20; 23(27):6674-81. PubMed ID: 16170175 [Abstract] [Full Text] [Related]
12. [Comparison of treatment efficacy of the second and the third generations of chemoradiotherapy regimens containing platinum on advanced non-small cell lung cancer]. Wang YM, Guo LJ, Li LS, Li P, Zheng J, Li L. Ai Zheng; 2005 Dec 20; 24(12):1514-7. PubMed ID: 16351804 [Abstract] [Full Text] [Related]
13. [Prognostic analysis of stage III-IV non-small cell lung cancer patients treated by traditional chinese medicine]. Zhou DH, Lin LZ, Zhou YQ, Luo RC, Liu KF, Jia YJ, Chen JY, Niu XW, Su BR, Lu J, Wang ST. Ai Zheng; 2005 Oct 20; 24(10):1252-6. PubMed ID: 16219143 [Abstract] [Full Text] [Related]
14. Enzastaurin, an oral serine/threonine kinase inhibitor, as second- or third-line therapy of non-small-cell lung cancer. Oh Y, Herbst RS, Burris H, Cleverly A, Musib L, Lahn M, Bepler G. J Clin Oncol; 2008 Mar 01; 26(7):1135-41. PubMed ID: 18309949 [Abstract] [Full Text] [Related]